Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26?
Portfolio Pulse from
Pfizer's stock could rise to $36 per share, according to a Wall Street analyst. The stock recently increased due to a dividend raise and positive management guidance.
December 19, 2024 | 11:30 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pfizer's stock is projected to rise to $36 per share by a Wall Street analyst. The stock has recently increased due to a dividend raise and positive management guidance.
The analyst's price target of $36 suggests a significant upside from the current price of $26, which is likely to attract investor interest. The recent dividend raise and management's positive guidance further support a bullish outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100